v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss, Net
Beginning balance (shares) at Dec. 31, 2020   5,949,463      
Beginning balance at Dec. 31, 2020 $ (15,540,812) $ 5,949 $ 110,107,170 $ (123,665,970) $ (1,987,961)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 408,295     408,295  
Share-based compensation to employees 4,471   4,471    
Accretion of Series A redeemable convertible preferred stock (197,114)   (197,114)    
Dividends on Series A redeemable convertible preferred stock (277,170)   (277,170)    
Foreign currency translation 86,398       86,398
Ending balance (shares) at Mar. 31, 2021   5,949,463      
Ending balance at Mar. 31, 2021 (15,515,932) $ 5,949 109,637,357 (123,257,675) (1,901,563)
Beginning balance (shares) at Dec. 31, 2020   5,949,463      
Beginning balance at Dec. 31, 2020 (15,540,812) $ 5,949 110,107,170 (123,665,970) (1,987,961)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 394,635        
Accretion of Series A redeemable convertible preferred stock (285,814)        
Dividends on Series A redeemable convertible preferred stock (848,898)        
Foreign currency translation 92,802        
Ending balance (shares) at Sep. 30, 2021   7,074,364      
Ending balance at Sep. 30, 2021 (12,487,667) $ 7,074 112,671,753 (123,271,335) (1,895,159)
Beginning balance (shares) at Mar. 31, 2021   5,949,463      
Beginning balance at Mar. 31, 2021 (15,515,932) $ 5,949 109,637,357 (123,257,675) (1,901,563)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (362,300)     (362,300)  
Sale of common stock in public offering, net of underwriting discounts and offering costs, Shares   811,750      
Sale of common stock in public offering, net of underwriting discounts and offering costs, Value 2,737,770 $ 812 2,736,958    
Share-based compensation to employees 4,697   4,697    
Shares issued in connection with vesting of restricted stock (shares)   28,151      
Shares issued in connection with vesting of restricted stock 0 $ 28 (28)    
Accretion of Series A redeemable convertible preferred stock (75,183)   (75,183)    
Dividends on Series A redeemable convertible preferred stock (282,926)   (282,926)    
Foreign currency translation (4,740)       (4,740)
Ending balance (shares) at Jun. 30, 2021   6,789,364      
Ending balance at Jun. 30, 2021 (13,498,614) $ 6,789 112,020,875 (123,619,975) (1,906,303)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 348,640     348,640  
Sale of common stock in public offering, net of underwriting discounts and offering costs, Shares   285,000      
Sale of common stock in public offering, net of underwriting discounts and offering costs, Value 948,566 $ 285 948,281    
Share-based compensation to employees 4,916   4,916    
Accretion of Series A redeemable convertible preferred stock (13,517)   (13,517)    
Dividends on Series A redeemable convertible preferred stock (288,802)   (288,802)    
Foreign currency translation 11,144       11,144
Ending balance (shares) at Sep. 30, 2021   7,074,364      
Ending balance at Sep. 30, 2021 (12,487,667) $ 7,074 112,671,753 (123,271,335) (1,895,159)
Beginning balance (shares) at Dec. 31, 2021   7,082,276      
Beginning balance at Dec. 31, 2021 (12,965,983) $ 7,082 112,349,613 (123,462,638) (1,860,040)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (1,109,406)     (1,109,406)  
Share-based compensation to employees 8,184   8,184    
Accretion of Series A redeemable convertible preferred stock (14,815)   (14,815)    
Dividends on Series A redeemable convertible preferred stock (300,921)   (300,921)    
Foreign currency translation 33,510       33,510
Ending balance (shares) at Mar. 31, 2022   7,082,276      
Ending balance at Mar. 31, 2022 (14,349,431) $ 7,082 112,042,061 (124,572,044) (1,826,530)
Beginning balance (shares) at Dec. 31, 2021   7,082,276      
Beginning balance at Dec. 31, 2021 (12,965,983) $ 7,082 112,349,613 (123,462,638) (1,860,040)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (1,819,260)        
Accretion of Series A redeemable convertible preferred stock (90,420)        
Dividends on Series A redeemable convertible preferred stock (1,030,365)        
Foreign currency translation 170,375        
Ending balance (shares) at Sep. 30, 2022   7,111,801      
Ending balance at Sep. 30, 2022 (15,700,382) $ 7,112 111,264,069 (125,281,898) (1,689,665)
Beginning balance (shares) at Mar. 31, 2022   7,082,276      
Beginning balance at Mar. 31, 2022 (14,349,431) $ 7,082 112,042,061 (124,572,044) (1,826,530)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (931,226)     (931,226)  
Share-based compensation to employees 19,102   19,102    
Shares issued in connection with vesting of restricted stock (shares)   29,525      
Shares issued in connection with vesting of restricted stock 0 $ 30 (30)    
Accretion of Series A redeemable convertible preferred stock (35,582)   (35,582)    
Dividends on Series A redeemable convertible preferred stock (338,428)   (338,428)    
Foreign currency translation 110,861       110,861
Ending balance (shares) at Jun. 30, 2022   7,111,801      
Ending balance at Jun. 30, 2022 (15,524,704) $ 7,112 111,687,123 (125,503,270) (1,715,669)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 221,372     221,372  
Share-based compensation to employees 7,985   7,985    
Accretion of Series A redeemable convertible preferred stock (40,023)   (40,023)    
Dividends on Series A redeemable convertible preferred stock (391,016)   (391,016)    
Foreign currency translation 26,004       26,004
Ending balance (shares) at Sep. 30, 2022   7,111,801      
Ending balance at Sep. 30, 2022 $ (15,700,382) $ 7,112 $ 111,264,069 $ (125,281,898) $ (1,689,665)